Uro Gen

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:academic_programs gptkb:Dr._Emily_White
gptkbp:acquired gptkb:Uro_Gen_Pharma_Ltd.
gptkbp:advertising gptkb:Dr._Sarah_Green
Dr. Nancy Yellow
Dr. Paul Orange
gptkbp:awards various industry awards
gptkbp:ceo Liz Barrett
gptkbp:clinical_trial Phase 3 trials
ongoing studies
gptkbp:collaborates_with academic institutions
gptkbp:conducts_research_on gptkb:Dr._David_P._M._H._Hwang
gptkbp:customer_support gptkb:Dr._George_Wood
gptkbp:develops therapeutics for urological cancers
gptkbp:employees over 100
gptkbp:focuses_on gptkb:disease
bladder cancer
urothelial carcinoma
uro-oncology
gptkbp:founded gptkb:2010
gptkbp:has_authority_over gptkb:Dr._Tom_Blue
gptkbp:head gptkb:Dr._Kevin_Grey
gptkbp:head_of_commercial_operations gptkb:Dr._Jane_Smith
gptkbp:head_of_state gptkb:Dr._Lisa_Black
gptkb:Dr._Richard_Roe
gptkb:Dr._Alan_Brown
gptkb:Dr._Anna_Gold
gptkb:Dr._Michael_A._M._H._Hwang
Dr. Frank Clay
gptkbp:headquarters gptkb:New_York_City
https://www.w3.org/2000/01/rdf-schema#label Uro Gen
gptkbp:instruction_set multiple drug candidates
gptkbp:investment gptkb:Dr._Rachel_Purple
institutional investors
gptkbp:military_service gptkb:Dr._Chris_Silver
gptkbp:mission improve patient outcomes
gptkbp:partnership with Merck
gptkbp:product gptkb:Uro_Gen's_RTGel
gptkb:Jelmyto
gptkbp:provides_training_for gptkb:Dr._Alice_Steel
gptkbp:public_relations gptkb:Dr._Betty_Stone
gptkb:Dr._Steve_Pink
gptkbp:regulatory_compliance gptkb:Dr._John_Doe
gptkb:Dr._Julia_Bronze
FDA approved products
gptkbp:research_and_development innovative therapies
gptkbp:research_areas oncology
urology
gptkbp:risk_management gptkb:Dr._Henry_Copper
gptkbp:strategic_goals gptkb:Dr._Laura_Cyan
gptkbp:supply_chain gptkb:Dr._Mark_Brown
gptkbp:traded_on gptkb:NASDAQ
gptkbp:website www.urogen.com
gptkbp:bfsParent gptkb:Taris_Biomedical
gptkbp:bfsLayer 5